224 related articles for article (PubMed ID: 32517673)
1. Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study.
Ito M; Kodaira T; Koide Y; Okuda T; Mizumatsu S; Oshima Y; Takeuchi A; Mori T; Abe S; Asai A; Suzuki K
BMC Cancer; 2020 Jun; 20(1):540. PubMed ID: 32517673
[TBL] [Abstract][Full Text] [Related]
2. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
3. Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma.
Yamamoto T; Niibe Y; Matsumoto Y; Onishi H; Aoki M; Nishikawa A; Oh RJ; Shintani T; Yahara K; Ozaki M; Manabe Y; Jingu K
J Radiat Res; 2020 Nov; 61(6):935-944. PubMed ID: 32940330
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Body Radiotherapy of Lymph Node Oligometastases.
Burkoň P; Oberreiterová S; Kazda T; Slávik M; Bobek L; Komínek L; Procházka T; Vrzal M; Šlampa P
Klin Onkol; 2020; 33(2):114-122. PubMed ID: 32303132
[TBL] [Abstract][Full Text] [Related]
5. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for response to salvage stereotactic body radiotherapy in oligorecurrent prostate cancer limited to lymph nodes: a single institution experience.
Oehler C; Zimmermann M; Adam L; Curschmann J; Sumila M; Strebel RT; Cathomas R; Li Q; Schneider U; Zwahlen DR
BMC Urol; 2019 Sep; 19(1):84. PubMed ID: 31500621
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy for pelvic boost in gynecological cancer patients with local recurrence or unsuitable for intracavitary brachytherapy.
Cheng HY; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Chen SW
Taiwan J Obstet Gynecol; 2021 Jan; 60(1):111-118. PubMed ID: 33494982
[TBL] [Abstract][Full Text] [Related]
8. Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.
Yeung R; Hamm J; Liu M; Schellenberg D
Radiat Oncol; 2017 Jun; 12(1):105. PubMed ID: 28637480
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis.
Poon I; Erler D; Dagan R; Redmond KJ; Foote M; Badellino S; Biswas T; Louie AV; Lee Y; Atenafu EG; Ricardi U; Sahgal A
JAMA Netw Open; 2020 Nov; 3(11):e2026312. PubMed ID: 33196810
[TBL] [Abstract][Full Text] [Related]
10. Salvage radiotherapy in patients affected by oligorecurrent pelvic nodal prostate cancer.
Ingrosso G; Mariucci C; Tenti MV; Bini V; Alì E; Saldi S; Palumbo I; Bellavita R; Aristei C
Clin Transl Oncol; 2020 Dec; 22(12):2236-2243. PubMed ID: 32418156
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Recurrence in Node-Positive Cervical Cancer Patients Treated With Contemporary Chemoradiation and Dose Escalation: A Multi-Institutional Study.
Sethi R; Mayadev J; Sethi S; Rash D; Chen LM; Brooks R; Ueda S; Hsu IC
Pract Radiat Oncol; 2019 Mar; 9(2):e180-e186. PubMed ID: 30342181
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
Parks J; Kloecker G; Woo S; Dunlap NE
Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534
[TBL] [Abstract][Full Text] [Related]
13. Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.
Thibault I; Campbell M; Tseng CL; Atenafu EG; Letourneau D; Yu E; Cho BC; Lee YK; Fehlings MG; Sahgal A
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):353-60. PubMed ID: 26383680
[TBL] [Abstract][Full Text] [Related]
14. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
[TBL] [Abstract][Full Text] [Related]
15. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
[TBL] [Abstract][Full Text] [Related]
16. Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases.
Kalinauskaite GG; Tinhofer II; Kufeld MM; Kluge AA; Grün AA; Budach VV; Senger CC; Stromberger CC
BMC Cancer; 2020 May; 20(1):404. PubMed ID: 32393261
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control.
Rwigema JM; King C; Wang PC; Kamrava M; Kupelian P; Steinberg ML; Lee P
Pract Radiat Oncol; 2015; 5(3):e183-e191. PubMed ID: 25413386
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
Shahi J; Poon I; Ung YC; Tsao M; Bjarnason GA; Malik NH; Zhang L; Louie AV; Cheung P
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):764-774. PubMed ID: 33115687
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers.
Reshko LB; Baliga S; Crandley EF; Harry Lomas IV; Richardson MK; Spencer K; Bennion N; Mikdachi HE; Irvin W; Kersh CR
Gynecol Oncol; 2020 Dec; 159(3):611-617. PubMed ID: 33059914
[TBL] [Abstract][Full Text] [Related]
20. Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy.
Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
Acta Oncol; 2019 Jan; 58(1):74-80. PubMed ID: 30280633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
